AR088600A1 - Composiciones de yodo-povidona - Google Patents
Composiciones de yodo-povidonaInfo
- Publication number
- AR088600A1 AR088600A1 ARP120104081A ARP120104081A AR088600A1 AR 088600 A1 AR088600 A1 AR 088600A1 AR P120104081 A ARP120104081 A AR P120104081A AR P120104081 A ARP120104081 A AR P120104081A AR 088600 A1 AR088600 A1 AR 088600A1
- Authority
- AR
- Argentina
- Prior art keywords
- percent
- weight
- composition
- hydrogenated
- iodine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/18—Iodine; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Dispersion Chemistry (AREA)
- Dermatology (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Detergent Compositions (AREA)
Abstract
Una composición que incluye entre 4 por ciento en peso y 12 por ciento en peso de un complejo povidona-yodo, entre 0,1 por ciento en peso y 2 por ciento en peso de una amida terciaria, sal de amida terciaria, y/o hidrato de amida terciaria, entre 0,5 por ciento en peso y 2 por ciento en peso de un emoliente con baja reactividad al yodo, al menos un tensioactivo, y agua. La composición tiene un pH entre 2,0 y 3,5. Reivindicación 8: La composición de la reivindicación 1, caracterizada porque el emoliente con baja reactividad al yodo se selecciona entre los grupos que consisten en aceite de jojoba, ésteres de aceite de jojoba hidrogenado, polibutenos hidrogenados, isododecano, tribehenato de glicerilo, aceite de ricino hidrogenado, aceite de palma, derivados de los mismos y combinaciones de los mismos.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161553503P | 2011-10-31 | 2011-10-31 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR088600A1 true AR088600A1 (es) | 2014-06-18 |
Family
ID=48192689
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP120104081A AR088600A1 (es) | 2011-10-31 | 2012-10-31 | Composiciones de yodo-povidona |
Country Status (11)
Country | Link |
---|---|
US (3) | US20130121953A1 (es) |
EP (1) | EP2773201B1 (es) |
AR (1) | AR088600A1 (es) |
BR (1) | BR112014010564A2 (es) |
CL (1) | CL2014001112A1 (es) |
CO (1) | CO7010827A2 (es) |
CR (1) | CR20140186A (es) |
EC (1) | ECSP14002959A (es) |
HK (1) | HK1201687A1 (es) |
PE (1) | PE20141580A1 (es) |
WO (1) | WO2013066909A1 (es) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
LT2688410T (lt) * | 2011-03-25 | 2017-10-10 | Delaval Holding Ab | Mažai paviršinio aktyvumo medžiagos turinti vietinio dezinfikavimo jodu priemonė |
EP3310334A1 (en) * | 2015-06-22 | 2018-04-25 | Infection Containment Company, LLC | Topical antiseptic system |
CN113318122B (zh) * | 2021-03-24 | 2022-06-24 | 厦门大开生物科技有限公司 | 一种含有聚维酮碘的消毒剂组合物及其用途 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5716611A (en) * | 1996-01-02 | 1998-02-10 | Euro-Celtique, S.A. | Emollient antimicrobial formulations containing povidone iodine |
US6436379B1 (en) * | 1997-10-17 | 2002-08-20 | International Flora Technologies Ltd. | Emollient for cuticle treatment and delivery system therefore |
US6559182B1 (en) * | 2001-11-07 | 2003-05-06 | Purcell Jojoba International, Llc | Method for treatment of enveloped viruses using jojoba oil esters |
US20040122105A1 (en) * | 2002-09-20 | 2004-06-24 | Griscom Bettle | Transdermal compositions |
BR112012028451A2 (pt) * | 2010-05-07 | 2016-07-19 | Microdermis Corp | composição tópica de iodopovidona |
-
2012
- 2012-10-31 PE PE2014000614A patent/PE20141580A1/es not_active Application Discontinuation
- 2012-10-31 BR BR112014010564A patent/BR112014010564A2/pt not_active IP Right Cessation
- 2012-10-31 EP EP12846028.4A patent/EP2773201B1/en not_active Not-in-force
- 2012-10-31 WO PCT/US2012/062643 patent/WO2013066909A1/en active Application Filing
- 2012-10-31 AR ARP120104081A patent/AR088600A1/es unknown
- 2012-10-31 US US13/664,729 patent/US20130121953A1/en not_active Abandoned
-
2014
- 2014-04-24 CR CR20140186A patent/CR20140186A/es unknown
- 2014-04-29 CL CL2014001112A patent/CL2014001112A1/es unknown
- 2014-05-22 CO CO14110583A patent/CO7010827A2/es unknown
- 2014-05-30 EC ECIEPI20142959A patent/ECSP14002959A/es unknown
-
2015
- 2015-03-06 HK HK15102278.2A patent/HK1201687A1/xx unknown
-
2018
- 2018-05-02 US US15/969,703 patent/US20180243424A1/en not_active Abandoned
- 2018-12-20 US US16/228,025 patent/US20190117783A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CO7010827A2 (es) | 2014-07-31 |
PE20141580A1 (es) | 2014-11-20 |
US20180243424A1 (en) | 2018-08-30 |
EP2773201A4 (en) | 2015-05-20 |
BR112014010564A2 (pt) | 2017-04-25 |
CL2014001112A1 (es) | 2014-07-11 |
EP2773201B1 (en) | 2017-12-06 |
CR20140186A (es) | 2014-08-28 |
ECSP14002959A (es) | 2017-05-31 |
US20130121953A1 (en) | 2013-05-16 |
US20190117783A1 (en) | 2019-04-25 |
HK1201687A1 (en) | 2015-09-11 |
WO2013066909A1 (en) | 2013-05-10 |
EP2773201A1 (en) | 2014-09-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DOP2016000298A (es) | Pirazolopiridinas y pirazolopirimidinas | |
CO2018003134A2 (es) | Composiciones para el cuidado bucal que comprenden un aminoácido básico, una combinación de fuentes de iones de zinc y un sistema quelante | |
CU20170077A7 (es) | Compuesto derivado de benzamida sustituida con 1,3-tiazol-2-ilo útil para el tratamiento de trastornos neurogénicos, composiciones y combinaciones que lo comprende | |
AR089274A1 (es) | Composicion de grasa | |
BR112014009031A2 (pt) | formulações de etanercept estabilizadas com íons de metais | |
BR112015017405A2 (pt) | composições que incluem agentes hidrofobizantes e estabilizantes e métodos para preparação e utilização das mesmas | |
CL2008001194A1 (es) | Composicion farmaceutica que comprende florfenico, una ciclodextrina y agua, un solvente y7o una mezcka de los mismos, con al menos 5% de solvente; kit que la contiene; complejo de florfenicol, util para tratr enfermedades respiratorias en animales | |
AR082252A1 (es) | Composiciones farmaceuticas moduladoras de c-met | |
BR112015014477A2 (pt) | composições para limpeza pessoal contendo aminoácido de zinco/haleto de trimetilglicina | |
ECSP14004812A (es) | Triazolopiridinas sustituidas | |
BR112015000229A2 (pt) | formulações aquosas estáveis de etanercept | |
AR089269A1 (es) | Composiciones para el cuidado oral | |
UY35276A (es) | Nuevos compuestos que inhiben la actividad de Lp-PLA2 | |
AR094012A1 (es) | Composiciones estables con peroxido para el cuidado oral | |
AR082422A1 (es) | Composicion detergente liquida | |
AR081819A1 (es) | Derivados de pirimidil-piperidinil-oxipiridinona, composiciones farmaceuticas que los contienen y uso de los mismos para tratar diabetes, dislipemias, obesidad y otras enfermedades | |
AR091039A1 (es) | Composiciones farmaceuticas topicas que comprenden terbinafina, uso y metodo de tratamiento | |
EA201591067A1 (ru) | Неводные композиции для ухода за полостью рта | |
AR088600A1 (es) | Composiciones de yodo-povidona | |
PE20100154A1 (es) | Pregn-4-en-21,17-carbolactonas sustituidas en el anillo c, asi como preparados farmaceuticos que las contienen | |
BR112015006464A2 (pt) | composição farmacêutica compreendendo rebamipida | |
CL2012003282A1 (es) | Composicion farmaceutica topica que comprende, en base al peso total de la composicion a) 0,01 a 0,2% en peso de furoato de mometasona, b) 5 a 18% en peso de hexilenglicol, c) 20 a 40% en peso de agua y d) 25 a 70% en peso de una fase oleosa; y su uso para tratar o prevenir psoriasis, dermatitis atopica, entre otros. | |
UY32408A (es) | Macrolido anti-inflamatorio | |
AR097143A1 (es) | Composición alimenticia mineral para lamer para rumiantes y método para prepararla | |
BR112015000275A2 (pt) | utilização de um extrato de mirta como agente anti-biopelícula face p. acnes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |